Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Quantitative Approaches to Assess Key Carcinogenic Events of Genotoxic Carcinogens

  • Fukushima, Shoji (Association for Promotion of Research on Risk Assessment) ;
  • Gi, Min (Department of Molecular Pathology, Osaka City University Graduate School of Medicine) ;
  • Fujioka, Masaki (Department of Molecular Pathology, Osaka City University Graduate School of Medicine) ;
  • Kakehashi, Anna (Department of Molecular Pathology, Osaka City University Graduate School of Medicine) ;
  • Wanibuchi, Hideki (Department of Molecular Pathology, Osaka City University Graduate School of Medicine) ;
  • Matsumoto, Michiharu (Japan Bioassay Research Center)
  • Received : 2018.07.23
  • Accepted : 2018.08.30
  • Published : 2018.10.15
Download PDF
⟨ Previous Next ⟩

Abstract

Chemical carcinogenesis is a multistep process. Genotoxic carcinogens, which are DNA-reactive, induce DNA adduct formation and genetic alterations in target cells, thereby generating mutated cells (initiation). Subsequently, preneoplastic lesions appear through clonal proliferation of the mutated cells and transform into tumors (promotion and progression). Many factors may influence these processes in a dose-dependent manner. Therefore, quantitative analysis plays an important role in studies on the carcinogenic threshold of genotoxic carcinogens. Herein, we present data on the relationship between key carcinogenic events and their deriving point of departure (PoD). Their PoDs were also compared to those of the carcinogenesis pathway. In an experiment, the liver of rats exposed to 2-amino-3,8-dimethylimidazo-(4,5-f)quinoxaline (MeIQx) was examined to determine the formation of MeIQx-DNA adducts, generation of mutations at LacI transgene, and induction of preneoplastic glutathione S-transferase placental form (GST-P)-positive foci and tumors (benign and malignant). The PoDs of the above key events in the carcinogenicity of MeIQx were increased as the carcinogenesis advanced; however, these PoDs were lower than those of tumor induction. Thus, the order of key events during tumor induction in the liver was as follows: formation of DNA adducts ${\ll}$ Mutations ${\ll}$ GST-positive foci (preneoplasia) ${\ll}$ Tumor (adenoma and carcinoma). We also obtained similar data on the genotoxic and carcinogenic PoDs of other hepatocarcinogens, such as 2-amino-3,8-dimethylimidazo(4,5-f)quinoline. These results contribute to elucidating the existence of a genotoxic and carcinogenic threshold.

Keywords

References

  1. Farmer, J.H., Kodell, R.L., Greenman, D.L. and Shaw, G.W. (1980) Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously. J. Environ. Pathol. Toxicol., 3, 55-68.
  2. Peto, R., Gray, R., Brantom, P. and Grasso, P. (1991) Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res., 51, 6415-6451.
  3. Ito, N., Tamano, S. and Shirai, T. (2003) A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci., 94, 3-8. https://doi.org/10.1111/j.1349-7006.2003.tb01343.x
  4. Kato, T., Ohgaki, H., Hasegawa, H., Sato, S., Takayama, S. and Sugimura, T. (1988) Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Carcinogenesis, 9, 71-73. https://doi.org/10.1093/carcin/9.1.71
  5. Kushida, H., Wakabayashi, K., Sato, H., Katami, M., Kurosaka, R. and Nagao, M. (1994) Dose-response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett., 83, 31-35. https://doi.org/10.1016/0304-3835(94)90295-X
  6. IARC (1993) IARC monographs on the evaluation of carcinogenic risks to humans: Some nuturally occurring substances: food items and constituents, heterocylic aromatic amines and mycotoxins. MeIQx (2-amino-3,8-dimethylimidazo( 4,5-f)quinoxaline), World Health Organization, International Agency for Research on Cancer, Lyon.
  7. Fukushima, S., Wanibuchi, H., Morimura, K., Wei, M., Nakae, D., Konishi, Y., Tsuda, H., Uehara, N., Imaida, K., Shirai, T., Tatematsu, M., Tsukamoto, T., Hirose, M., Furukawa, F., Wakabayashi, K. and Totsuka, Y. (2002) Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine. Jpn J. Cancer Res., 93, 1076-1082. https://doi.org/10.1111/j.1349-7006.2002.tb01208.x
  8. Hoshi, M., Morimura, K., Wanibuchi, H., Wei, M., Okochi, E., Ushijima, T., Takaoka, K. and Fukushima, S. (2004) Noobserved effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen. Toxicol. Sci., 81, 273-279. https://doi.org/10.1093/toxsci/kfh241
  9. Fukushima, S., Wanibuchi, H., Morimura, K., Wei, M., Nakae, D., Konishi, Y., Tsuda, H., Takasuka, N., Imaida, K., Shirai, T., Tatematsu, M., Tsukamoto, T., Hirose, M. and Furukawa, F. (2003) Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Cancer Lett., 191, 35-40. https://doi.org/10.1016/S0304-3835(02)00631-6
  10. Murai, T., Mori, S., Kang, J.S., Morimura, K., Wanibuchi, H., Totsuka, Y. and Fukushima, S. (2008) Evidence of a threshold-effect for 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline liver carcinogenicity in F344/DuCrj rats. Toxicol. Pathol., 36, 472-477. https://doi.org/10.1177/0192623308315671
  11. MacGregor, J.T., Frotschl, R., White, P.A., Crump, K.S., Eastmond, D.A., Fukushima, S., Guerard, M., Hayashi, M., Soeteman-Hernandez, L.G., Kasamatsu, T., Levy, D.D., Morita, T., Muller, L., Schoeny, R., Schuler, M.J., Thybaud, V. and Johnson, G.E. (2015) IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs). Mutat. Res. Genet. Toxicol. Environ. Mutagen., 783, 55-65. https://doi.org/10.1016/j.mrgentox.2014.09.011
  12. MacGregor, J.T., Frotschl, R., White, P.A., Crump, K.S., Eastmond, D.A., Fukushima, S., Guerard, M., Hayashi, M., Soeteman-Hernandez, L.G., Johnson, G.E., Kasamatsu, T., Levy, D.D., Morita, T., Muller, L., Schoeny, R., Schuler, M.J. and Thybaud, V. (2015) IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of pointof-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 783, 66-78. https://doi.org/10.1016/j.mrgentox.2014.10.008
  13. Kang, J.S., Wanibuchi, H., Morimura, K., Totsuka, Y., Yoshimura, I. and Fukushima, S. (2006) Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide-induced liver damage in rats. Cancer Sci., 97, 453-458. https://doi.org/10.1111/j.1349-7006.2006.00201.x
  14. Wei, M., Hori, T.A., Ichihara, T., Wanibuchi, H., Morimura, K., Kang, J.S., Puatanachokchai, R. and Fukushima, S. (2006) Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats. Cancer Lett., 231, 304-308. https://doi.org/10.1016/j.canlet.2005.02.029
  15. Ohgaki, H., Hasegawa, H., Kato, T., Suenaga, M., Ubukata, M., Sato, S., Takayama, S. and Sugimura, T. (1986) Carcinogenicity in mice and rats of heterocyclic amines in cooked foods. Environ. Health Perspect., 67, 129-134. https://doi.org/10.1289/ehp.8667129
  16. IARC (1993) IARC monographs on the evaluation of carcinogenic risks to humans: Some nuturally occurring substances: food items and constituents, heterocylic aromatic amines and mycotoxins. IQ (2-amino-3-methylimidazo(4,5-f)quinoline), World Health Organization, International Agency for Research on Cancer, Lyon.
  17. Wei, M., Wanibuchi, H., Nakae, D., Tsuda, H., Takahashi, S., Hirose, M., Totsuka, Y., Tatematsu, M. and Fukushima, S. (2011) Low-dose carcinogenicity of 2-amino-3-methylimidazo[ 4,5-f]quinoline in rats: Evidence for the existence of no-effect levels and a mechanism involving p21(Cip/WAF1). Cancer Sci., 102, 88-94. https://doi.org/10.1111/j.1349-7006.2010.01761.x
  18. Fukushima, S., Gi, M., Kakehashi, A. and Wanibuchi, H. (2016) Qualitative and quantitative assessment on low-dose carcinogenicity of genotoxic hepatocarcinogens: Dose-response for key events in rat hepatocarcinogenesis in Thresholds of Genotoxic Carcinogen (Nohmi, T. and Fukushima, S. Eds.). Academic Press, pp. 1-17.

Cited by

  1. Perspectives on trace chemical safety and chemophobia: risk communication and risk management pp.1087-2620, 2019, https://doi.org/10.1080/15287394.2019.1575625